Integrating Discovery, Improving Efficiency

RubrYc Therapeutics Discovery-Stage Pipeline

RubrYc’s pipeline of products includes several proprietary therapeutic antibody programs targeting unique epitopes across multiple therapeutic areas.

RTX-003
Anti-CD 25 mediated Treg Depletion
Solid tumors
RTX-002
PD-1 Agonist
Autoimmune
1st Co-Discovery
Undisclosed Oncology Target
Solid tumors